Evidence map›Paper›PMID 27926858›Full record

ArticleCell reports2016

G-Protein-Coupled Receptor-2-Interacting Protein-1 Controls Stalk Cell Fate by Inhibiting Delta-like 4-Notch1 Signaling.

Syamantak Majumder, GuoFu Zhu, Xiangbin Xu, Sharon Senchanthisai, Dongyang Jiang, Hao Liu, Chao Xue, Xiaoqun Wang, Heidi Coia, Zhaoqiang Cui and 4 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. The endothelial tip-stalk cell selection and shuffling during angiogenesis.Journal of cell communication and signaling · 2019
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Syamantak MajumderAab Cardiovascular Research Institute, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA.
GuoFu ZhuDepartment of Cardiology, Pan-Vascular Research Institute, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China.
Xiangbin XuDepartment of Microbiology and Immunology, University of Rochester Medical Center, Rochester, NY 14642, USA.
Sharon SenchanthisaiAab Cardiovascular Research Institute, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA.
Dongyang JiangDepartment of Cardiology, Pan-Vascular Research Institute, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China.
Hao LiuDepartment of Cardiology, Pan-Vascular Research Institute, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China.
Chao XueAab Cardiovascular Research Institute, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA.
Xiaoqun WangAab Cardiovascular Research Institute, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA.
Heidi CoiaAab Cardiovascular Research Institute, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA.
Zhaoqiang CuiAab Cardiovascular Research Institute, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA.
Elaine M SmolockAab Cardiovascular Research Institute, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA.
Richard T LibbyFlaum Eye Institute, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA.
Bradford C BerkAab Cardiovascular Research Institute, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA.
Jinjiang PangAab Cardiovascular Research Institute, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA; Department of Cardiology, Pan-Vascular Research Institute, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China. Electronic address: jinjiang_pang@urmc.rochester.edu.
University of Rochester · USShanghai Tenth People's Hospital · CNTongji University · CNUniversity of Rochester Medical Center · US

Funding

ANGIOTENSIN II SIGNAL TRANSDUCTIONR01HL063462 · NHLBI · UNIVERSITY OF ROCHESTER · PI BERK, BRADFORD C · 1999 to 2012
$4.3M
The novel mechanisms of HIV associated vascular cognitive impairmentR01HL122777 · NHLBI · UNIVERSITY OF ROCHESTER · PI PANG, JINJIANG · 2014 to 2023
$4.1M
NHLBI NIH HHS R01 HL063462NHLBI NIH HHS R01 HL122777
6 · The paper itself

Abstract

The spatiotemporal localization and expression of Dll4 are critical for sprouting angiogenesis. However, the related mechanisms are poorly understood. Here, we show that G-protein-coupled receptor-kinase interacting protein-1 (GIT1) is a robust endogenous inhibitor of Dll4-Notch1 signaling that specifically controls stalk cell fate. GIT1 is highly expressed in stalk cells but not in tip cells. GIT1 deficiency remarkably enhances Dll4 expression and Notch1 signaling, resulting in impaired retinal sprouting angiogenesis, which can be rescued by treatment with the Notch inhibitor or Dll4 neutralizing antibody. Notch1 regulates Dll4 expression by binding to recombining binding protein suppressor of hairless (RBP-J, a transcriptional regulator of Notch) via a highly conserved ankyrin (ANK) repeat domain. We show that GIT1, which also contains an ANK domain, inhibits the Notch1-Dll4 signaling pathway by competing with Notch1 ANK domain for binding to RBP-J in stalk cells.

Indexed as

Adaptor Proteins, Signal TransducingCell Cycle ProteinsCell DifferentiationCell ProliferationEndothelial CellsGene Expression RegulationHumansHuman Umbilical Vein Endothelial CellsImmunoglobulin J Recombination Signal Sequence-Binding ProteinIntracellular Signaling Peptides and ProteinsMembrane ProteinsNeovascularization, PhysiologicProtein BindingReceptor, Notch1Signal TransductionAdaptor Proteins, Signal TransducingCell Cycle Proteinsdelta proteinGIT1 protein, humanImmunoglobulin J Recombination Signal Sequence-Binding ProteinIntracellular Signaling Peptides and ProteinsMembrane ProteinsRBPJ protein, humanReceptor, Notch1Delta-like 4G-protein-coupled receptor-2-interacting protein1stalk cell fate

Identifiers

PMID27926858
PMCPMC5217468
OpenAlexW2560780080

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.